Walicka-Serzysko, K.; Postek, M.; Mielus, M.; Borawska-Kowalczyk, U.; Milczewska, J.; Zybert, K.; Wozniacki, Ł.; Wołkowicz, A.; Sands, D.
Comprehensive Evaluation of Elexacaftor/Tezacaftor/Ivacaftor in Paediatric Cystic Fibrosis: Nutritional, Pulmonary, and Quality-of-Life Outcomes. J. Clin. Med. 2025, 14, 7969.
https://doi.org/10.3390/jcm14227969
AMA Style
Walicka-Serzysko K, Postek M, Mielus M, Borawska-Kowalczyk U, Milczewska J, Zybert K, Wozniacki Ł, Wołkowicz A, Sands D.
Comprehensive Evaluation of Elexacaftor/Tezacaftor/Ivacaftor in Paediatric Cystic Fibrosis: Nutritional, Pulmonary, and Quality-of-Life Outcomes. Journal of Clinical Medicine. 2025; 14(22):7969.
https://doi.org/10.3390/jcm14227969
Chicago/Turabian Style
Walicka-Serzysko, Katarzyna, Magdalena Postek, Monika Mielus, Urszula Borawska-Kowalczyk, Justyna Milczewska, Katarzyna Zybert, Łukasz Wozniacki, Anna Wołkowicz, and Dorota Sands.
2025. "Comprehensive Evaluation of Elexacaftor/Tezacaftor/Ivacaftor in Paediatric Cystic Fibrosis: Nutritional, Pulmonary, and Quality-of-Life Outcomes" Journal of Clinical Medicine 14, no. 22: 7969.
https://doi.org/10.3390/jcm14227969
APA Style
Walicka-Serzysko, K., Postek, M., Mielus, M., Borawska-Kowalczyk, U., Milczewska, J., Zybert, K., Wozniacki, Ł., Wołkowicz, A., & Sands, D.
(2025). Comprehensive Evaluation of Elexacaftor/Tezacaftor/Ivacaftor in Paediatric Cystic Fibrosis: Nutritional, Pulmonary, and Quality-of-Life Outcomes. Journal of Clinical Medicine, 14(22), 7969.
https://doi.org/10.3390/jcm14227969